CODRITUZUMAB
UNII U9I0PLD4HT

Substance Identification & Data

This profile provides standardized clinical and technical data for Codrituzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U9I0PLD4HT.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1365267-33-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
U9I0PLD4HT
CAS Registry Number
1365267-33-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CODRITUZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
9759
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Codrituzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CODRITUZUMAB

Common Names & Synonyms

ANTI-GPC3 MONOCLONAL ANTIBODY GC33
CODRITUZUMAB [INN]
CODRITUZUMAB [WHO-DD]

Technical Codes

GC33
GC-33
RG7686
RG-7686
RO5137382
RO-5137382